Value Framework ICER is actively publishing and updating health technology assessment methodologies and value frameworks, presenting opportunities to align offerings with their evaluation criteria and support evidence-based pricing discussions.

Evidence Driven As a non-profit research institute focusing on evidence-based reviews of therapies and diagnostics, ICER presents a potential market for collaborative evidence generation, data analysis partnerships, and validated value demonstrations for new interventions.

Policy and Access ICER reports on barriers to care and recommends solutions for fair access to prescription drugs, signaling potential for partnerships around patient access programs, pricing transparency, and policy impact studies.

Therapy Coverage Recent HTA outputs and final evidence reports on novel therapies (including gene therapies for sickle cell disease and Alzheimer's drugs) indicate demand for rigorous health economics analyses, payer-aligned outcomes data, and real-world evidence generation services.

Tech Modernization ICER’s tech stack includes cloud and analytics tools; there may be opportunities to provide integrated data collection, visualization, and stakeholder engagement platforms that streamline their evidence review and dissemination processes.